Reuters logo
BRIEF-Neothetics initiates phase 2 proof of concept trial for lipo-202
December 23, 2016 / 1:13 PM / 9 months ago

BRIEF-Neothetics initiates phase 2 proof of concept trial for lipo-202

Dec 23 (Reuters) - Neothetics Inc :

* Expects to report top-line data from this trial in late Q2 2017

* Neothetics initiates phase 2 proof of concept trial for lipo-202 for the reduction of submental subcutaneous fat Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below